Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (459) 459
Newspaper Article (12) 12
Book / eBook (5) 5
Book Chapter (2) 2
Magazine Article (2) 2
Newsletter (1) 1
Video Recording (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (276) 276
life sciences & biomedicine (271) 271
humans (234) 234
ophthalmology (230) 230
female (166) 166
male (166) 166
middle aged (102) 102
aged (97) 97
biological and medical sciences (88) 88
abridged index medicus (86) 86
medical sciences (80) 80
adult (62) 62
macular degeneration (62) 62
clinical trials (57) 57
risk factors (57) 57
aged, 80 and over (54) 54
visual acuity - physiology (51) 51
visual acuity (46) 46
fluorescein angiography (44) 44
follow-up studies (38) 38
physiological aspects (38) 38
retinopathies (37) 37
vascular endothelial growth factor a - antagonists & inhibitors (36) 36
comparative analysis (35) 35
angiogenesis inhibitors - therapeutic use (34) 34
research (34) 34
prospective studies (33) 33
tomography, optical coherence (33) 33
treatment outcome (32) 32
bevacizumab (31) 31
child, preschool (30) 30
cohort studies (30) 30
cross-sectional studies (30) 30
intravitreal injections (29) 29
drug therapy (28) 28
analysis (27) 27
care and treatment (27) 27
eye diseases (27) 27
ranibizumab (27) 27
incidence (25) 25
reproducibility of results (24) 24
macular degeneration - drug therapy (23) 23
macular degeneration - complications (22) 22
wet macular degeneration - drug therapy (22) 22
animals (20) 20
health aspects (20) 20
adolescent (19) 19
antibodies, monoclonal, humanized - therapeutic use (19) 19
miscellaneous (19) 19
vascular endothelial growth factor (19) 19
child (18) 18
retina - pathology (17) 17
sensitivity and specificity (17) 17
age (16) 16
diabetes (16) 16
diabetic retinopathy (16) 16
eye (16) 16
laser coagulation (16) 16
macular degeneration - physiopathology (16) 16
photography (16) 16
time factors (16) 16
wet macular degeneration - diagnosis (16) 16
prevalence (15) 15
choroid - blood supply (14) 14
general & internal medicine (14) 14
infant, newborn (14) 14
medicine, general & internal (14) 14
vision disorders - diagnosis (14) 14
angiogenesis inhibitors - administration & dosage (13) 13
diagnosis (13) 13
fundus oculi (13) 13
genetic structures (13) 13
mice (13) 13
neurosciences & neurology (13) 13
ranibizumab - therapeutic use (13) 13
retina (13) 13
retinopathy (13) 13
surveys and questionnaires (13) 13
wet macular degeneration - physiopathology (13) 13
antibodies, monoclonal, humanized - administration & dosage (12) 12
bevacizumab - therapeutic use (12) 12
blood pressure (12) 12
choroidal neovascularization - diagnosis (12) 12
disease progression (12) 12
double-blind method (12) 12
edema (12) 12
online first (12) 12
vision disorders - physiopathology (12) 12
medical research (11) 11
neurology (11) 11
neurosciences (11) 11
patients (11) 11
choroidal neovascularization - drug therapy (10) 10
choroidal neovascularization - etiology (10) 10
choroidal neovascularization - physiopathology (10) 10
diabetes mellitus (10) 10
dietary supplements (10) 10
gestational age (10) 10
infants (10) 10
macular degeneration - diagnosis (10) 10
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Criminology - Stacks (1) 1
Gerstein Science - Stacks (1) 1
Markham Stouffville Hospital - Stacks (1) 1
Media Commons - Audio Visual (1) 1
OISE - Stacks (1) 1
St. Michael's College (John M. Kelly) - Audio Visual (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Steps Forward in Analyzing Optical Coherence Tomography in Age-Related Macular Degeneration—Capitalizing on the Power of Artificial Intelligence
by Maguire, Maureen G
JAMA ophthalmology, ISSN 2168-6165, 07/2020, Volume 138, Issue 7, pp. 747 - 748
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Macular degeneration | Artificial intelligence | Age | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Updated Methods for Assessing the Risk of Progression to Late Age-Related Macular Degeneration
by Maguire, Maureen G
JAMA ophthalmology, ISSN 2168-6165, 07/2019, Volume 137, Issue 7, pp. 745 - 746
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Demography | Humans | Disease Progression | Macular Degeneration | Macular degeneration | Eye | Age | Blindness | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Assessing Intereye Symmetry and Its Implications for Study Design
by Maguire, Maureen G
Investigative ophthalmology & visual science, ISSN 0146-0404, 06/2020, Volume 61, Issue 6, pp. 27 - 27
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Understanding Variation in Response to Anti–Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
by Maguire, Maureen G
JAMA ophthalmology, ISSN 2168-6165, 05/2018, Volume 136, Issue 8, pp. 884 - 885
Life Sciences & Biomedicine | Ophthalmology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Reply
by Maguire, Maureen G
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 03/2017, Volume 124, Issue 3, p. e33
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Further Scrutiny of Vision Outcomes When Aflibercept Is Used as Rescue Treatment for Eyes With Diabetic Macular Edema Treated With Laser
by Maguire, Maureen G
JAMA ophthalmology, ISSN 2168-6165, 12/2016, Volume 135, Issue 2, pp. 114 - 115
Life Sciences & Biomedicine | Ophthalmology | Science & Technology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
by Martin, Daniel F., MD and Maguire, Maureen G., PhD and Fine, Stuart L., MD and Ying, Gui-shuang, PhD and Jaffe, Glenn J., MD and Grunwald, Juan E., MD and Toth, Cynthia, MD and Redford, Maryann, DDS, MPH and Ferris, Frederick L., MD and Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group and Comparison Age-related Macular
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2012, Volume 119, Issue 7, pp. 1388 - 1398
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Macular degeneration | Care and treatment | Angiogenesis inhibitors | Drug therapy | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Treatment Choice for Diabetic Macular Edema
by Martin, Daniel F and Maguire, Maureen G
The New England journal of medicine, ISSN 0028-4793, 03/2015, Volume 372, Issue 13, pp. 1260 - 1261
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Diabetic Retinopathy - drug therapy | Visual Acuity - drug effects | Antibodies, Monoclonal, Humanized - administration & dosage | Humans | Macular Edema - drug therapy | Ranibizumab | Female | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Recombinant Fusion Proteins - administration & dosage | Bevacizumab | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Dropsy | Edema | Diabetics | Care and treatment | Analysis | Outcome and process assessment (Health Care) | Health aspects | Risk factors | Eye | Drugs | Diabetic retinopathy | Diabetes mellitus | Vision | Clinical trials | Retina | Diabetes | Drug therapy | Vascular endothelial growth factor | Eyes & eyesight | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Visual Impairment Is More Common in Parkinson’s Disease and Is a Risk Factor for Poor Health Outcomes
by Hamedani, Ali G and Abraham, Danielle S and Maguire, Maureen G and Willis, Allison W
Movement disorders, ISSN 0885-3185, 09/2020, Volume 35, Issue 9, pp. 1542 - 1549
visual impairment | epidemiology | outcomes research | Parkinson’s disease | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Eye | Medical research | Medical examination | Medicare | Depression, Mental | Medicine, Experimental | Epidemiology | Health aspects | Risk factors | Dementia | Parkinson's disease | Neurodegenerative diseases | Mental disorders | Parkinsons disease | Mental depression | Hip | Fractures | Visual impairment | Anxieties | Dementia disorders | Anxiety | Movement disorders | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration
by Ying, Gui-shuang, PhD and Huang, Jiayan, MS and Maguire, Maureen G., PhD and Jaffe, Glenn J., MD and Grunwald, Juan E., MD and Toth, Cynthia, MD and Daniel, Ebenezer, MBBS, MS, MPH and Klein, Michael, MD and Pieramici, Dante, MD and Wells, John, MD and Martin, Daniel F., MD and Comparison of Age-related Macular Degeneration Treatments Trials Research Group and Comparison Age-Related Macular
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2013, Volume 120, Issue 1, pp. 122 - 129
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Monoclonal, Humanized - therapeutic use | Intravitreal Injections | Tomography, Optical Coherence | Humans | Middle Aged | Male | Treatment Outcome | Wet Macular Degeneration - physiopathology | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Bevacizumab | Wet Macular Degeneration - drug therapy | Time Factors | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Aged | Visual Acuity - physiology | Cohort Studies | Fluorescein Angiography | Macular degeneration | Physiological aspects | Medical colleges | Angiogenesis inhibitors | Consulting services | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials
by Jaffe, Glenn J., MD and Martin, Daniel F., MD and Toth, Cynthia A., MD and Daniel, Ebenezer, MPH, PhD and Maguire, Maureen G., PhD and Ying, Gui-Shuang, PhD and Grunwald, Juan E., MD and Huang, Jiayan, MS and Comparison of Age-related Macular Degeneration Treatments Trials Research Group and Comparison Age-related Macular
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2013, Volume 120, Issue 9, pp. 1860 - 1870
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Monoclonal, Humanized - therapeutic use | Prospective Studies | Follow-Up Studies | Macular Degeneration - physiopathology | Tomography, Optical Coherence | Humans | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Bevacizumab | Ranibizumab | Subretinal Fluid | Angiogenesis Inhibitors - therapeutic use | Visual Acuity - physiology | Fluorescein Angiography | Macula Lutea - pathology | Macular degeneration | Clinical trials | Comparative analysis | Drug therapy | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Dose Response in Anti-VEGF Treatment for Neovascular Age-related Macular Degeneration: Is It Only the Number of Injections?
by Maguire, Maureen G
Retina (Philadelphia, Pa.), 01/2021
Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT)
by Hagstrom, Stephanie A., PhD and Ying, Gui-shuang, PhD and Pauer, Gayle J.T., BA and Sturgill-Short, Gwen M., BA and Huang, Jiayan, MS and Callanan, David G., MD and Kim, Ivana K., MD and Klein, Michael L., MD and Maguire, Maureen G., PhD and Martin, Daniel F., MD and Comparison of AMD Treatments Trials Research Group and Comparison AMD Treatments Trials R
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2013, Volume 120, Issue 3, pp. 593 - 599
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Prospective Studies | Humans | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Macular Degeneration - diagnosis | Macular Degeneration - drug therapy | Bevacizumab | Ranibizumab | Serine Endopeptidases - genetics | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Complement C3 - genetics | Visual Acuity - physiology | Fluorescein Angiography | Pharmacogenetics | Antibodies, Monoclonal, Humanized - therapeutic use | Tomography, Optical Coherence | Gene Frequency | High-Temperature Requirement A Serine Peptidase 1 | Genotype | Proteins - genetics | Macular Degeneration - genetics | Aged | Polymorphism, Single Nucleotide | Complement Factor H - genetics | Macular degeneration | Genes | Physiological aspects | Clinical trials | Genetic aspects | Angiogenesis inhibitors | Comparative analysis | Single nucleotide polymorphisms | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Growth of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
by Grunwald, Juan E., MD and Pistilli, Maxwell, MS and Ying, Gui-shuang, PhD and Maguire, Maureen G., PhD and Daniel, Ebenezer, MBBS, MD and Martin, Daniel F., MD and Comparison of Age-related Macular Degeneration Treatments Trials Research Group and Comparison Age Related Macular Deg
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2015, Volume 122, Issue 4, pp. 809 - 816
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Geographic Atrophy - genetics | Intravitreal Injections | Humans | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Wet Macular Degeneration - genetics | Bevacizumab | Ranibizumab | Serine Endopeptidases - genetics | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Toll-Like Receptor 3 - genetics | Complement C3 - genetics | Visual Acuity - physiology | Fluorescein Angiography | Antibodies, Monoclonal, Humanized - therapeutic use | High-Temperature Requirement A Serine Peptidase 1 | Photography | Proteins - genetics | Wet Macular Degeneration - diagnosis | Geographic Atrophy - pathology | Wet Macular Degeneration - drug therapy | Aged | Polymorphism, Single Nucleotide | Complement Factor H - genetics | Cohort Studies | Macular degeneration | Growth | Physiological aspects | Clinical trials | Comparative analysis | Drug therapy | Vascular endothelial growth factor | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Risk of Geographic Atrophy in the Comparison of Age-related Macular Degeneration Treatments Trials
by Grunwald, Juan E., MD and Daniel, Ebenezer, MBBS, MD and Huang, Jiayan, MS and Ying, Gui-shuang, PhD and Maguire, Maureen G., PhD and Toth, Cynthia A., MD and Jaffe, Glenn J., MD and Fine, Stuart L., MD and Blodi, Barbara, MD and Klein, Michael L., MD and Martin, Alison A and Hagstrom, Stephanie A., PhD and Martin, Daniel F., MD and CATT Research Group and CATT Res Grp
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2014, Volume 121, Issue 1, pp. 150 - 161
Ophthalmology | Life Sciences & Biomedicine | Science & Technology | Follow-Up Studies | Geographic Atrophy - diagnosis | Humans | Middle Aged | Geographic Atrophy - drug therapy | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Genotyping Techniques | Bevacizumab | Incidence | Ranibizumab | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Female | Visual Acuity - physiology | Fluorescein Angiography | Geographic Atrophy - epidemiology | Wet Macular Degeneration - epidemiology | Antibodies, Monoclonal, Humanized - therapeutic use | Risk Factors | Proportional Hazards Models | Wet Macular Degeneration - diagnosis | Wet Macular Degeneration - drug therapy | Aged | Cohort Studies | Macular degeneration | Clinical trials | Physiological aspects | Comparative analysis | Drug therapy | Risk factors | Biomedical engineering | Medical research | Medicine, Experimental | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights